GlassScriptPhysician profile
Chrys A Manos
NPI 1376641753
$5,173.10
in general payments reported to CMS, 2019-2025
19 companies · $708 in 2025
The $708 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $811 · 2020: $691 · 2021: $745 · 2022: $502 · 2023: $986 · 2024: $731 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,234 · Entertainment: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,234.33 |
| Entertainment | $190.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,199.10 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $649.50 | 2020-2025 | Total30, Precision7, Tryptyr |
| Optos, INC. | $571.36 | 2019-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Lkc Technologies, INC. | $379.29 | 2023-2025 | |
| Allergan, INC. | $342.49 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $326.24 | 2019-2021 | |
| Abbvie INC. | $318.47 | 2022-2024 | |
| Sight Sciences, INC. | $307.34 | 2021-2023 | Tearcare System |
| Maculogix, INC. | $289.91 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $204.43 | 2025 | Xdemvy |
| Shire North American Group INC | $133.59 | 2019 | |
| Bausch & Lomb Americas INC. | $90.52 | 2022-2025 | Infuse, Miebo, Xiidra |
| Abb Con-Cise Optical Group LLC | $87.43 | 2021 | |
| Novartis Pharmaceuticals Corporation | $59.76 | 2019-2022 | |
| Oyster Point Pharma, INC. | $59.57 | 2022-2024 | Tyrvaya |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $53.99 | 2019-2024 | Cequa |
| Johnson & Johnson Vision Care, INC. | $52.22 | 2023 | Acuvue |
| Alcon Research LLC | $30.59 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $17.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chrys Manos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.